The potentially devastating consequences of a relapse in patients with schizophrenia and the substantial risk of relapse associated with even partial compliance with therapy have made compliance a ...

Adult Risperidone-naive: rule out risperidone hypersensitivity before using injection. Give by deep deltoid or gluteal IM inj; alternate sides. Give with oral risperidone (or other antipsychotic) for ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a long-acting subcutaneous risperidone injection for the treatment of schizophrenia in adults.

The RISE study 7 was a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of risperidone extended-release injectable suspension for subcutaneous use as a ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics ®, a clinical-stage biopharmaceutical company, today announced positive data from the STARLYNG-1 (LYN-005-C-301) study, comparing the ...

FDA approves UZEDY® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I ...

'How Can It Be Enough?': Thousands Have Agreed to the Risperdal Settlement. A Few Holdouts Remain According to attorneys leading the litigation, more than 5,600 have agreed to the settlement, which is ...

NEW YORK (Reuters) - A Philadelphia jury on Friday found that Johnson & Johnson’s Janssen Pharmaceuticals failed to warn that antipsychotic drug Risperdal could cause male breast growth, in a case ...

(Adds analyst comment, updates share price) NEW YORK, April 11 (Reuters) - Teva Pharmaceutical Industries Ltd <TEVA.O> said on Friday a U.S. court granted a request that would give the Israeli company ...

Adult Risperidone-naive: rule out risperidone hypersensitivity before using injection. Give by deep deltoid or gluteal IM inj; alternate sides. Give with oral risperidone (or other antipsychotic) for ...